(Q38178875)

30 August 2017

title

Stem cell therapies and regenerative medicine in China (English)

1 reference

30 August 2017

main subject

regenerative medicine

1 reference

Sha Huang

1

1 reference

30 August 2017

XiaoBing Fu

series ordinal

2

1 reference

30 August 2017

language of work or name

1 reference

15 January 2014

1 reference

Science in China. Series C: Life Sciences

30 August 2017

published in

1 reference

30 August 2017

volume

57

1 reference

30 August 2017

issue

2

1 reference

30 August 2017

page(s)

157-161

1 reference

Hopes and fears for professional movement in the stem cell community

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

China's policies on stem cell research: an opportunity for international collaborations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Regeneration of functional sweat gland-like structures by transplanted differentiated bone marrow mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

FDA regulation of stem-cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

The promise and perils of stem cell therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Signalling pathways that control vertebrate haematopoietic stem cell specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Bone marrow transplantation from the personal viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Exploring the application of mesenchymal stem cells in bone repair and regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Cardiac cell therapy: lessons from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Hematopoietic stem cells are pluripotent and not just "hematopoietic".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Human umbilical cord blood stem cells, myocardial infarction and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Non-haematological uses of cord blood stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Umbilical cord blood transplantation for non-malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Clinical trials for stem cell therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Immunological considerations for embryonic and induced pluripotent stem cell banking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Embryonic stem cell trials for macular degeneration: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Designing materials to direct stem-cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Cell delivery mechanisms for tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

The Alpha Stem Cell Clinic: a model for evaluating and delivering stem cell-based therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Regulation of stem cell therapies under attack in Europe: for whom the bell tolls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Product regulation and the clinical translation of stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Stem cell tourism and doctors' duties to minors--a view from Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

New ISSCR guidelines underscore major principles for responsible translational stem cell research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-014-4608-3

10.1007/S11427-014-4608-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1039174297

0 references

1 reference